The European drug authority recommends refusal of marketing authorization after study shows no benefit over placebo.

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

As Medicare turns 60, Medscape convened an expert panel to discuss the use of AI in medicine, physician reimbursement, and ...

Even in people without high blood pressure, subclinical primary aldosteronism is linked to a significantly higher risk for ...

As Medicare turns 60, Medscape convened an expert panel to discuss the successes — and shortcomings — of this landmark ...

As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer ...

Influencers on social media tout the benefits of okra-infused water for glucose control. But experts are skeptical — at best.

This is especially true for older adults with type 2 diabetes (T2D) taking insulin and/or sulfonylureas — steadfast older ...

In recently reported case studies, nemolizumab, approved for two indications associated with itch, has been reported to be ...

Psychiatrists challenge common suicide myths and explain why smiling patients still face life-threatening risks.

As Medicare turns 60, Medscape convened an expert panel to discuss if physicians can survive without the program and the ways ...

The Mediterranean diet has long been touted as one of the healthiest diets in the world, but childhood obesity in Greece has ...